Anti-TNF-α therapy for uveitis: Behçet and beyond
Open Access
- 8 August 2005
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 19 (8) , 831-833
- https://doi.org/10.1038/sj.eye.6701792
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Infliximab for chronic cystoid macular edema associated with uveitisAmerican Journal of Ophthalmology, 2004
- Etanercept treatment in the endotoxin-induced uveitis of ratsExperimental Eye Research, 2004
- Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)Eye, 2004
- The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU)Progress in Retinal and Eye Research, 2004
- Neutralizing Tumor Necrosis Factor Activity Leads to Remission in PatientsWith Refractory Noninfectious Posterior UveitisArchives of Ophthalmology (1950), 2004
- Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritisOphthalmology, 2004
- Infliximab in the treatment of refractory posterior uveitisOphthalmology, 2003
- Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's diseaseAnnals of the Rheumatic Diseases, 2002
- Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical UveitisOphthalmic Research, 2001
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997